Herpes simplex virus type 1 preferentially targets human colon carcinoma: Role of extracellular matrix

Journal of Virology

Volumn 82, Issue 2, 2008, Pages 999-1010

  Kolodkin Gal, Dror ^a   Zamir, Gideon ^a   Edden, Yair ^a   Pikarsky, Eli ^a   Pikarsky, Alon ^a   Haim, Hillel ^a   Haviv, Yosef S ^a   Panet, Amos ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COLLAGEN; LENTIVIRUS VECTOR; MUCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COLON CARCINOGENESIS; CONTROLLED STUDY; EPITHELIUM CELL; EX VIVO STUDY; EXTRACELLULAR MATRIX; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN TISSUE; INTRACELLULAR SPACE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; VIROTHERAPY;

ANIMALS; CARCINOMA; COLLAGEN; COLONIC NEOPLASMS; EXTRACELLULAR MATRIX; HERPESVIRUS 1, HUMAN; HUMANS; MALE; MICE; MUCINS; ONCOLYTIC VIROTHERAPY; ORGAN CULTURE TECHNIQUES;

HUMAN HERPESVIRUS 1;

EID: 37849032052     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01769-07     Document Type: Article

References (55)

1. Alian, A., D. Sela-Donenfeld, A. Panet, and A. Eldor. 2000. Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene. Virology 276:161-168.
2. Allen, A., D. A. Hutton, and J. P. Pearson. 1998. The MUC2 gene product: a human intestinal mucin. Int. J. Biochem. Cell. Biol. 30:797-801.
3. Bischoff, J. R., D. H. Kirn, A. Williams, C. Heise, S. Horn, M. Muna, L. Ng, J. A. Nye, A. Sampson-Johannes, A. Fattaey, and F. McCormick. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376.
4. Blau, S., N. Levin, B. Schwartz, and A. Rubinstein. 2001. Adsorption of cationized bovine serum albumin onto epithelial crypt fractions of the rat colon. J. Pharm. Sci. 90:1516-1522.
5. Bourcier, T., P. Forgez, V. Borderie, S. Scheer, W. Rostene, and L. Laroche. 2000. Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone. Investig. Ophthalmol. Vis. Sci. 41:4133-4141.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Braun, E., T. Zimmerman, T. B. Hur, E. Reinhartz, Y. Fellig, A. Panet, and I. Steiner. 2006. Neurotropism of herpes simplex virus type 1 in brain organ cultures. J. Gen. Virol. 87:2827-2837.
8. Brill-Almon, E., B. Stern, D. Afik, J. Kaye, N. Langer, S. Bellomo, M. Shavit, A. Pearlman, Y. Lippin, A. Panet, and N. Shani. 2005. Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. Mol. Ther. 12:274-282.
9. Byrd, J. C., and R. S. Bresalier. 2004. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23:77-99.
10. Campadelli-Fiume, G., F. Cocchi, L. Menotti, and M. Lopez. 2000. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 10:305-319.
11. Chen, C. C., M. Baylor, and D. M. Bass. 1993. Murine intestinal mucins inhibit rotavirus infection. Gastroenterology 105:84-92.
12. Dambach, M. J., J. Trecki, N. Martin, and N. S. Markovitz. 2006. Oncolytic viruses derived from the gamma34.5-deleted herpes simplex virus recombinant R3616 encode a truncated UL3 protein. Mol. Ther. 13:891-898.
13. Goldstein, D. J., and S. K. Weller. 1988. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J. Virol. 62:196-205.
14. Hassen, E., Y. Slovatizky, Y. Shimoni, H. Falk, A. Panet, and E. Mitrani. 2005. Solid tissues can be manipulated ex vivo and used as vehicles for gene therapy. J. Gene Med. 7:926-935.
15. Haviv, Y. S., J. L. Blackwell, A. Kanerva, P. Nagi, V. Krasnykh, I. Dmitriev, M. Wang, S. Naito, X. Lei, A. Hemminki, D. Carey, and D. T. Curiel. 2002. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res. 62:4273-4281.
16. Hemminki, A., A. Kanerva, B. Liu, M. Wang, R. D. Alvarez, G. P. Siegal, and D. T. Curiel. 2003. Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. Cancer Res. 63:847-853.
17. Henke, M. O., A. Renner, R. M. Huber, M. C. Seeds, and B. K. Rubin. 2004. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am. J. Respir. Cell Mol. Biol. 31:86-91.
18. Hoppe, S., M. Schelhaas, V. Jaeger, T. Liebig, P. Petermann, and D. Knebel-Morsdorf. 2006. Early herpes simplex virus type 1 infection is dependent on regulated Rac1/Cdc42 signalling in epithelial MDCKII cells. J. Gen. Virol. 87:3483-3494.
19. Jass, J. R., and M. D. Walsh. 2001. Altered mucin expression in the gastrointestinal tract: a review. J. Cell Mol. Med. 5:327-351.
20. Kanerva, A., M. Wang, G. J. Bauerschmitz, J. T. Lam, R. A. Desmond, S. M. Bhoola, M. N. Barnes, R. D. Alvarez, G. P. Siegal, D. T. Curiel, and A. Hemminki. 2002. Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses. Mol. Ther. 5:695-704.
21. Kirby, T. O., A. Rivera, D. Rein, M. Wang, I. Ulasov, M. Breidenbach, M. Kataram, J. L. Contreras, C. Krumdieck, M. Yamamoto, M. G. Rots, H. J. Haisma, R. D. Alvarez, P. J. Mahasreshti, and D. T. Curiel. 2004. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity. Clin. Cancer Res. 10:8697-8703.
22. Kolodkin-Gal, D., G. Zamir, E. Pikarski, A. Pikarski, N. Shimony, H. Wu, Y. S. Haviv, and A. Panet. 2007. A novel system to study adenovirus tropism to normal and malignant colon tissues. Virology 357:91-101.
23. Kuriyama, N., H. Kuriyama, C. M. Julin, K. R. Lamborn, and M. A. Israel. 2001. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model. Cancer Res. 61:1805-1809.
24. Larkin, L. M., S. Calve, T. Y. Kostrominova, and E. M. Arruda. 2006. Structure and functional evaluation of tendon-skeletal muscle constructs engineered in vitro. Tissue Eng. 12:3149-3158.
25. Marozin, S., U. Prank, and B. Sodeik. 2004. Herpes simplex virus type 1 infection of polarized epithelial cells requires microtubules and access to receptors present at cell-cell contact sites. J. Gen. Virol. 85:775-786.
26. Martuza, R. L., A. Malick, J. M. Markert, K. L. Ruffner, and D. M. Coen. 1991. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252:854-856.
27. Matsuda, K., T. Masaki, T. Watanabe, J. Kitayama, H. Nagawa, T. Muto, and Y. Ajioka. 2000. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma. Jpn. J. Clin. Oncol. 30:89-94.
28. McKee, T. D., P. Grandi, W. Mok, G. Alexandrakis, N. Insin, J. P. Zimmer, M. G. Bawendi, Y. Boucher, X. O. Breakefield, and R. K. Jain. 2006. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res. 66:2509-2513.
29. McKenzie, S. P., S. L. Barnes, and R. W. Schwartz. 2005. An update on the surgical management of rectal cancer. Curr. Surg. 62:407-411.
30. Meier, O., and U. F. Greber. 2004. Adenovirus endocytosis. J. Gene Med. 6(Suppl. 1):S152-S163.
31. Mineta, T., S. D. Rabkin, T. Yazaki, W. D. Hunter, and R. L. Martuza. 1995. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med. 1:938-943.
32. Mullen, J. T., H. Kasuya, S. S. Yoon, N. M. Carroll, T. M. Pawlik, S. Chandrasekhar, H. Nakamura, J. M. Donahue, and K. K. Tanabe. 2002. Regulation of herpes simplex virus 1 replication using tumor-associated promoters. Ann. Surg. 236:502-512.
33. Nakamura, T., K. W. Peng, S. Vongpunsawad, M. Harvey, H. Mizuguchi, T. Hayakawa, R. Cattaneo, and S. J. Russell. 2004. Antibody-targeted cell fusion. Nat. Biotechnol. 22:331-336.
34. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
35. Plotnikov, A., T. Tichler, R. Korenstein, and Y. Keisari. 2005. Involvement of the immune response in the cure of metastatic murine CT-26 colon carcinoma by low electric field-enhanced chemotherapy. Int. J. Cancer 117: 816-824.
36. Prevec, L., B. S. Christie, K. E. Laurie, M. M. Bailey, F. L. Graham, and K. L. Rosenthal. 1991. Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys. J. Acquir. Immune Defic. Syndr. 4:568-576.
37. Reinblatt, M., R. H. Pin, and Y. Fong. 2004. Carcinoembryonic antigen directed herpes viral oncolysis improves selectivity and activity in colorectal cancer. Surgery 136:579-584.
38. Rhodes, J. M. 1997. Mucins and inflammatory bowel disease. QJM 90:79-82.
39. Rivera, A. A., J. Davydova, S. Schierer, M. Wang, V. Krasnykh, M. Yamamoto, D. T. Curiel, and D. M. Nettelbeck. 2004. Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells. Gene Ther. 11:1694-1702.
40. Ross, H. M., N. Mahmoud, and R. D. Fry. 2005. The current management of rectal cancer. Curr. Probl. Surg. 42:72-131.
41. Rots, M. G., M. G. Elferink, W. M. Gommans, D. Oosterhuis, J. A. Schalk, D. T. Curiel, P. Olinga, H. J. Haisma, and G. M. Groothuis. 2006. An ex vivo human model system to evaluate specificity of replicating and non-replicating gene therapy agents. J. Gene Med. 8:35-41.
42. Sansonetti, P. J. 2004. War and peace at mucosal surfaces. Nat. Rev. Immunol. 4:953-964.
43. Schang, L. M., A. Bantly, and P. A. Schaffer. 2002. Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. J. Virol. 76:7724-7735.
44. Shayakhmetov, D. M., Z. Y. Li, S. Ni, and A. Lieber. 2002. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases. Cancer Res. 62:1063-1068.
45. Spear, P. G. 2004. Herpes simplex virus: receptors and ligands for cell entry. Cell. Microbiol. 6:401-410.
46. Stoff-Khalili, M. A., A. A. Rivera, L. P. Le, A. Stoff, M. Everts, J. L. Contreras, D. Chen, L. Teng, M. G. Rots, H. J. Haisma, R. P. Rocconi, G. J. Bauerschmitz, D. T. Rein, M. Yamamoto, G. P. Siegal, P. Dall, J. M. Mathis, and D. T. Curiel. 2006. Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents. Cancer Gene Ther. 13:606-618.
47. Stoff-Khalili, M. A., A. Stoff, A. A. Rivera, J. M. Mathis, M. Everts, M. Wang, Y. Kawakami, R. Waehler, Q. L. Mathews, M. Yamamoto, R. P. Rocconi, G. P. Siegal, D. F. Richter, P. Dall, Z. B. Zhu, and D. T. Curiel. 2005. Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. Cancer Biol. Ther. 4:1203-1210.
48. Stonebraker, J. R., D. Wagner, R. W. Lefensty, K. Burns, S. J. Gendler, J. M. Bergelson, R. C. Boucher, W. K. O'Neal, and R. J. Pickles. 2004. Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to luminal infection. J. Virol. 78:13755-13768.
49. Thomas, S., R. S. Coffin, P. Watts, G. Gough, and D. S. Latchman. 1998. The TAATGARAT motif in the herpes simplex virus immediate-early gene promoters can confer both positive and negative responses to cellular octamer-binding proteins when it is located within the viral genome. J. Virol. 72:3495-3500.
50. Thomas, S. K., G. Gough, D. S. Latchman, and R. S. Coffin. 1999. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency. J. Virol. 73:6618-6625.
51. van Beusechem, V. W., J. Grill, D. C. Mastenbroek, T. J. Wickham, P. W. Roelvink, H. J. Haisma, M. L. Lamfers, C. M. Dirven, H. M. Pinedo, and W. R. Gerritsen. 2002. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished. J. Virol. 76:2753-2762.
52. Varghese, S., and S. D. Rabkin. 2002. Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther. 9:967-978.
53. Walters, R. W., T. Grunst, J. M. Bergelson, R. W. Finberg, M. J. Welsh, and J. Zabner. 1999. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem. 274: 10219-10226.
54. Yamamura, H., M. Hashio, M. Noguchi, Y. Sugenoya, M. Osakada, N. Hirano, Y. Sasaki, T. Yoden, N. Awata, N. Araki, M. Tatsuta, S. I. Miyatake, and K. Takahashi. 2001. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors. Cancer Res. 61:3969-3977.
55. Zhang, J. G., S. Ghosh, C. D. Ockleford, and M. Galinanes. 2000. Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischaemia and reperfusion in man. Clin. Sci. (London) 99:443-453.